Lobbying

Neuronetics STIM's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q3 2023; the issues it reports most are Health Issues.

NeuroneticsSTIM

Neuronetics stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q3 2023
The first quarter a report named it

Lobbying by quarter

Neuronetics lobbying by quarter
Neuronetics lobbying by quarter
QuarterAmountReports
Q3 2023$30K1
Q4 2023$45K1
Q1 2024$45K1
Q2 2024$45K1
Q3 2024$01
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Health issues$165K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports

Firms it paid

Firm
The Vogel Group$165K5 quarters
Checkmate Government Relations$03 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/16for Q2Checkmate Government RelationsUnder $5,000
04/17for Q1Checkmate Government RelationsUnder $5,000
01/20for Q4 2025Checkmate Government RelationsUnder $5,000
25/11/03for Q4 2025Checkmate Government RelationsUnder $5,000
24/10/17for Q3 2024The Vogel GroupUnder $5,000
24/07/09for Q2 2024The Vogel Group$45K
24/04/19for Q1 2024The Vogel Group$45K
24/01/19for Q4 2023The Vogel Group$45K
23/10/25for Q3 2023The Vogel GroupUnder $5,000
23/10/18for Q3 2023The Vogel Group$30K
23/09/14for Q3 2023The Vogel GroupUnder $5,000